Schedule a consultation to discuss your goals with our team and begin your preparation for peptide therapy
Studies show comparable results to full-time bracing for appropriate candidates
On the pharmacology side, HGF-induced MET activation exerts beneficial neuroprotective effects also in adulthood, specifically in neurodegenerative disease, and in preclinical models of cerebral ischemia, spinal cord injuries, and neurological pathologies, such as Alzheimers disease (AD), amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS)
However, unlike traditional EPO, it does not increase red blood cell counts
Research studies have highlighted its ability to aid tissue repair, helping reduce chronic inflammation and speed injury healing